IPP Bureau
MicrobioTx launches IBS Risk Score to enable early detection of gut disorder
By IPP Bureau - April 20, 2026
The launch coincides with IBS Awareness Month in April
Apollo Hospitals appoints Dr Harit Kumar Chaturvedi as CEO
By IPP Bureau - April 20, 2026
Move to accelerate cancer care expansion across India
Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities
By IPP Bureau - April 20, 2026
PMDA is regarded among the most stringent regulatory bodies globally
Novartis CEO Vas Narasimhan joins Anthropic board
By IPP Bureau - April 20, 2026
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Axten Hospitals raises Rs 2.5 crore from PedalStart to scale surgical care network
By IPP Bureau - April 20, 2026
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering
By IPP Bureau - April 20, 2026
The innovation is particularly suited for bone and cartilage repair
Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court
By IPP Bureau - April 20, 2026
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
UICC report flags air pollution as major multi-cancer risk
By IPP Bureau - April 20, 2026
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools
By IPP Bureau - April 20, 2026
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
Eli Lilly flags counterfeit Mounjaro seizure in Gurugram
By IPP Bureau - April 20, 2026
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
By IPP Bureau - April 20, 2026
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection
By IPP Bureau - April 20, 2026
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
AWS unveils Amazon Bio Discovery to accelerate drug design with AI
By IPP Bureau - April 20, 2026
FDA pushes forward on gene-editing therapies with new safety roadmap
By IPP Bureau - April 20, 2026
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
